Dr. Wade L Lowry , MD
Urology • Bedford, TX
1604 Hospital Pkwy Ste 201
Bedford, TX 760226930
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on September 21, 2005; this date does not establish years in practice.
-
Published CMS data list 3,598 Original Medicare Part B services in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Published rows only; this is not a quality measure.
-
Published Part B service records, 2019:
- 99213 — Established patient outpatient office visit: 686 service units.
- 81003 — Automated urinalysis test: 684 service units.
- 36415 — Insertion of needle into vein for collection of blood sample: 280 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2018 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2019). CPT notice
See all 25 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 545 Medicare Part D prescriptions, including refills, in 2020.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020. Published rows only; this is not a quality measure.
-
Published Part D records, 2020:
- Tamsulosin Hcl — 273 prescription fills, including refills.
- Finasteride — 73 prescription fills, including refills.
- Oxybutynin Chloride Er (Oxybutynin Chloride) — 34 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 11 records in the table · Guide: How to read Medicare Part D prescriber data
-
Medicare Part B services went from 3,681 in 2017 to 3,598 in 2019.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2017–2019.
Practice Location & Contact Primary Location
1604 Hospital Pkwy Ste 201
Bedford, TX 760226930
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Urology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $183,019 in 2019
The total amount Medicare approved for these services in 2019. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
Paid by Medicare
About $139,284 in 2019
The part of the Medicare-allowed amount that Medicare itself paid in 2019, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019.
30-day fills
1,314 standardized 30-day fills in 2020
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$60,524 in 2020
The total cost of these prescriptions in 2020, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2020.
Open Payments general payments, program year 2019
All general payments: $151.14 across 9 records.
By nature of payment
- Food and Beverage: $151.14 across 9 records.
Reporting-company totals (3 largest of 8)
- ConvaTec Inc.: $26.23 across 2 records.
- Ferring Pharmaceuticals Inc.: $26.08 across 1 record.
- BOSTON SCIENTIFIC CORPORATION: $23.76 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2019 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Bedford and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Lowry are from 2019.
Medicare Part D
Comparisons use 2024 data. The latest CMS data for Dr. Lowry are from 2020.
3 active clinicians are listed under Urology with a practice address in Bedford, TX (961 in Texas).
Addresses are self-reported to NPPES and may be out of date.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services stayed about the same: 3,681 in 2017 and 3,598 in 2019.
- 2017: 3,681
- 2018: 4,479
- 2019: 3,598
-
Medicare-allowed amount
Medicare-allowed amount varied from year to year: $180,069 in 2017 and $183,019 in 2019.
- 2017: $180,069
- 2018: $251,278
- 2019: $183,019
-
Paid by Medicare
Paid by Medicare varied from year to year: $139,305 in 2017 and $139,284 in 2019.
- 2017: $139,305
- 2018: $194,635
- 2019: $139,284
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 76% from 2,253 in 2016 to 545 in 2020.
- 2016: 2,253
- 2017: 2,327
- 2018: 2,471
- 2019: 2,580
- 2020: 545
-
30-day fills
30-day fills decreased 67% from 3,984 in 2016 to 1,314 in 2020.
- 2016: 3,984
- 2017: 4,197
- 2018: 4,574
- 2019: 5,248
- 2020: 1,314
-
Part D drug cost
Part D drug cost decreased 67% from $182,116 in 2016 to $60,524 in 2020.
- 2016: $182,116
- 2017: $214,861
- 2018: $207,597
- 2019: $235,251
- 2020: $60,524
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2019 only.
Sources: CMS Medicare Physician & Other Practitioners (2019), CMS Medicare Part D Prescribers (2020), CMS Open Payments (2019), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2019 (payments made January 1 – December 31, 2019): fewer than 11 records totaling $151.14.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Ferring Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
NOCDURNA | General | $26.08 |
| BOSTON SCIENTIFIC CORPORATION |
Food and Beverage
In-kind items and services
|
GENERAL BPH | General | $23.76 |
| Avadel Specialty Pharmaceuticals, LLC |
Food and Beverage
In-kind items and services
|
Noctiva | General | $18.36 |
| Mission Pharmacal Company |
Food and Beverage
In-kind items and services
|
Uribel | General | $15.61 |
| ConvaTec Inc. |
Food and Beverage
Cash or cash equivalent
|
— | General | $15.41 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
XTANDI | General | $15.09 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
JEVTANA | General | $13.51 |
| Janssen Pharmaceuticals, Inc |
Food and Beverage
In-kind items and services
|
Erleada | General | $12.50 |
| ConvaTec Inc. |
Food and Beverage
Cash or cash equivalent
|
GENTLECATH | General | $10.82 |
Source: CMS Open Payments, program year 2019, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2018 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2019; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
686 | 536 | $150.00 | $73.82 |
|
81003
Automated urinalysis test
|
684 | 494 | $7.00 | $2.43 |
|
36415
Insertion of needle into vein for collection of blood sample
|
280 | 251 | $10.00 | $2.94 |
|
84153
Psa (prostate specific antigen) measurement, total
|
274 | 248 | $51.00 | $20.03 |
|
51798
Ultrasound measurement of bladder capacity after voiding
|
201 | 165 | $46.00 | $12.61 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
181 | 181 | $220.00 | $106.77 |
|
99231
Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes
|
164 | 70 | $80.00 | $39.03 |
|
87086
Bacterial colony count, urine
|
156 | 99 | $24.00 | $8.79 |
|
J0696
Injection, ceftriaxone sodium, per 250 mg
|
150 | 36 | $16.00 | $0.58 |
|
J9217
Leuprolide acetate (for depot suspension), 7.5 mg
|
132 | 17 | $1043.00 | $225.25 |
|
52000
Diagnostic exam of bladder and urethra using an endoscope
|
112 | 85 | $469.00 | $188.26 |
|
87077
Bacterial culture for aerobic isolates
|
94 | 59 | $24.00 | $8.79 |
|
87186
Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution
|
91 | 59 | $24.00 | $9.42 |
|
81001
Manual urinalysis test with examination using microscope, automated
|
87 | 71 | $9.00 | $3.42 |
|
99221
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes
|
70 | 64 | $206.00 | $101.31 |
|
81002
Urinalysis, manual test
|
40 | 40 | $7.00 | $3.41 |
|
55700
Biopsy of prostate gland
|
32 | 32 | $510.00 | $252.23 |
|
76942
Ultrasonic guidance for needle placement
|
32 | 32 | $360.00 | $57.28 |
|
96372
Injection of drug or substance under skin or into muscle
|
32 | 31 | $54.00 | $16.72 |
|
96402
Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
|
22 | 17 | $86.00 | $30.93 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
19 | 19 | $219.00 | $104.39 |
|
52332
Insertion of stent in ureter using an endoscope
|
17 | 14 | $1451.65 | $138.00 |
|
50590
Shock wave crushing of kidney stones
|
14 | 13 | $2060.00 | $553.26 |
|
52601
Removal of prostate gland using an electrocautery knife through urethra with control of bleeding using an endoscope
|
14 | 14 | $1902.00 | $745.86 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
14 | 12 | $147.00 | $72.94 |
Source: CMS Part B by Provider and Service, 2019; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2020.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Tamsulosin Hcl | Tamsulosin Hcl | 273 | 20,740 | $5,455.08 | 125 |
| Finasteride | Finasteride | 73 | 5,720 | $2,144.52 | 34 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 34 | 2,760 | $2,374.50 | 18 |
| Myrbetriq | Mirabegron | 34 | 2,352 | $33,264.28 | 14 |
| Alfuzosin Hcl Er | Alfuzosin Hcl | 33 | 2,778 | $1,151.88 | 16 |
| Toviaz | Fesoterodine Fumarate | 21 | 1,092 | $12,997.34 | — |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 21 | 930 | $1,045.69 | 12 |
| Solifenacin Succinate | Solifenacin Succinate | 17 | 750 | $1,048.84 | — |
| Bicalutamide | Bicalutamide | 16 | 708 | $612.76 | — |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 12 | 779 | $151.13 | — |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | 510 | $278.25 | — |
Source: CMS Part D by Provider and Drug, 2020; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 208800000X
A urologist manages benign and malignant medical and surgical disorders of the genitourinary system and the adrenal gland. This specialist has comprehensive knowledge of and skills in endoscopic, percutaneous and open surgery of congenital and acquired conditions of the urinary and reproductive systems and their contiguous structures.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Family
Nurse Practitioner
Urology
Doctor of Medicine (M.D.)
Urology
Doctor of Medicine (M.D.)
Physician Assistant - Medical
Physician Assistant (Certified)
Physician Assistant
Urology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 1604 HOSPITAL PKWY STE 201, BEDFORD, TX 760226930 (Tel: 8177848268)
Registered at 1604 HOSPITAL PKWY STE 201, BEDFORD, TX 760226930 (Tel: 8177848268)
NPI status registered as active in NPPES database
Registered at 1604 HOSPITAL PKWY, SUITE 202, BEDFORD, TX 760226986 (Tel: 8177848268)
Registered at 1604 HOSPITAL PKWY, SUITE 202, BEDFORD, TX 760226986 (Tel: 8177848268)
Recorded as WADE LOWRY, MD
Urology (license number reported to NPPES: TX G4641)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Urology Specialists in Bedford
Healthcare providers in BedfordMailing Address
1604 Hospital Pkwy Ste 201
Bedford, TX 760226930
Phone: 8177848268